E-tail may be generally stronger than physical stores on the sales and profits front, but in the festive period, bricks and mortar chains have beaten their pureplay rivals on one key measure - social media engagement.
India’s drugs regulator has ordered Johnson & Johnson to stop manufacturing its Baby Powder in two of its Indian factories until test results prove they are free of asbestos, a senior official said on Thursday.
E-sales growth in the run-up to Christmas may have been weaker than for some years, but that shouldn't hold Christmas Day e-spending back with a new prediction that it will reach a significant milestone this year.
Johnson & Johnson failed to persuade a Missouri trial judge to set aside a verdict awarding a record $4.69 billion to 22 women who blamed their ovarian cancer on asbestos in the company’s talc products.
The visits came as regulators in India launched an investigation into J&J’s Baby Powder following a Reuters report last Friday that the firm knew for decades that cancer-causing asbestos could be found in the product.
Slowing growth in e-tail in Britain reflected tough economic times and excessive Black Friday discounts a new report said on Wednesday, but discount fatigue seems to be setting in and the future is uncertain.
Shares of Johnson & Johnson slipped another 2 percent on Monday, extending losses following Friday’s Reuters report that the healthcare conglomerate knew for decades that cancer-causing asbestos was in its Baby Powder.